Personalis Announces Expansion of Scientific and Clinical Team; Deanna Church and Robert Nussbaum

Menlo Park, CA – Personalis, Inc., the leading provider of advanced medical exome and genome sequencing and interpretation services today announced that Deanna Church, Ph.D., has joined its R&D team, and Robert Nussbaum, M.D., Professor of Medicine and Chief of the Division of Genomic Medicine at UCSF, has joined its Clinical and Scientific Advisory Board.  Dr. Nussbaum will bring his deep expertise in medical genetics to guide development of Personalis’ next-generation sequencing (NGS) based clinical services.  Dr. Church comes to Personalis from the NCBI where she helped lead development of the newest Human Reference GRCh38 as well as genomic tools used by scientists worldwide.  “We are thrilled that both Dr. Nussbaum and Dr. Church are joining our team,” said Personalis Chief Scientific Officer Richard Chen, M.D.  “Dr. Nussbaum brings world class expertise to our clinical product development while Dr. Church’s deep expertise on the structure of the human genome, scientific tools and databases will help us continue to advance our application of NGS data to research and clinical use.”

“We are dedicated to pushing the envelope of accuracy, completeness and clinical utility in human genomic analysis, and Drs. Church and Nussbaum both share our vision and will be instrumental in helping us to advance it,” added Personalis CEO John West.


About Personalis, Inc.

Personalis, Inc. ( is a leading precision medicine company focused on advanced NGS-based clinical diagnostic, clinical trial and research services for cancer and inherited genetic disease.  Personalis also provides DNA sequencing and data analysis of human genomes.

The Personalis ACE Exome and Transcriptome technology is designed to obtain the most comprehensive and accurate tumor molecular profile for immuno-oncology applications. The company’s clinical laboratory is GCP compliant, CLIA licensed and CAP accredited.

Media Contact for Personalis:

Jennifer Havlek